BioCardia, Inc.
BCDA
Positions held
Your positionsBCDA isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $16.05M | Enterprise value | $12.22M | Trailing P/E | — | Forward P/E | -1.83 |
| PEG | — | Price / book | 5.89 | Beta | 0.62 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -18.0% | ROA | -135.0% | Debt / equity | 0.11 |
| Current ratio | 2.09 | Free cash flow | -$5.66M | Analyst recommendation | none | Mean target | $15.50 |
| 52w high | $1.80 | 52w low | $0.75 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | — | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — | — |
| Net income | — | -$2.3M | -$2.0M | -$1.5M | -$2.0M | -$2.7M |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | -$2.3M | -$2.0M | -$1.5M | -$2.1M | -$2.7M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.1M | $0.5M | $1.4M | — |
| Op margin | — | -13794.8% | -2441.1% | -880.3% | — |
| Net income | -$8.2M | -$7.9M | -$11.6M | -$11.9M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | $1.0M |
| Operating income | -$8.3M | -$8.0M | -$11.6M | -$11.9M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting
2026-10-01 · BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter
2026-09-23 · BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
2026-08-19 · BioCardia (BCDA) Q2 2026 Earnings Call Transcript
2026-08-13 · BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulatory Wins in Japan and US ...
2026-08-13 · BioCardia, Inc. Q2 2026 Earnings Call Summary
2026-08-12 · BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results
2026-08-05 · BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026
Price (daily)
Full chart · RSI · MACD · patterns